ONTX Annual Net Margin
N/A
31 December 2023
Summary:
ONTX annual net profit margin is not available.ONTX Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ONTX Quarterly Net Margin
N/A
31 March 2024
Summary:
ONTX quarterly net profit margin is not available.ONTX Quarterly Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ONTX Net Margin Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
ONTX Net Margin High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time |
Onconova Therapeutics Net Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | -8314.04%(+11.5%) |
| June 2023 | - | -7456.14%(-27.7%) |
| Mar 2023 | - | -10.31 K%(+6.5%) |
| Dec 2022 | -8391.15%(+17.3%) | -9678.57%(+2.2%) |
| Sept 2022 | - | -9470.18%(+34.1%) |
| June 2022 | - | -7059.65%(-4.1%) |
| Mar 2022 | - | -7360.71%(+9.5%) |
| Dec 2021 | -7151.77%(-34.3%) | -6721.43%(+11.0%) |
| Sept 2021 | - | -6057.89%(-18.4%) |
| June 2021 | - | -7422.81%(-11.8%) |
| Mar 2021 | - | -8419.64%(-25.4%) |
| Dec 2020 | -10.89 K%(+1005.6%) | -11.28 K%(+19.3%) |
| Sept 2020 | - | -9456.06%(-28.4%) |
| June 2020 | - | -13.21 K%(+34.9%) |
| Mar 2020 | - | -9792.31%(-48.9%) |
| Dec 2019 | -985.02%(-41.2%) | -19.16 K%(+162.6%) |
| Sept 2019 | - | -7293.65%(+4041.5%) |
| June 2019 | - | -176.11%(-98.4%) |
| Mar 2019 | - | -11.18 K%(+16.7%) |
| Dec 2018 | -1675.33%(-45.3%) | -9577.97%(+114.9%) |
| Sept 2018 | - | -4456.67%(+382.0%) |
| June 2018 | - | -924.54%(+2.4%) |
| Mar 2018 | - | -902.48%(-79.2%) |
| Dec 2017 | -3061.25% | -4340.56%(-31.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2017 | - | -6328.18%(+693.5%) |
| June 2017 | - | -797.53%(-79.9%) |
| Mar 2017 | - | -3971.90%(+26.2%) |
| Dec 2016 | -354.62%(+69.4%) | -3148.55%(+3151.0%) |
| Sept 2016 | - | -96.85%(-59.5%) |
| June 2016 | - | -239.37%(-51.3%) |
| Mar 2016 | - | -491.18%(-1576.8%) |
| Dec 2015 | -209.31%(-97.4%) | 33.26%(-109.2%) |
| Sept 2015 | - | -362.08%(-95.0%) |
| June 2015 | - | -7280.49%(-32.8%) |
| Mar 2015 | - | -10.83 K%(-7.7%) |
| Dec 2014 | -7960.25%(+504.9%) | -11.73 K%(-10.1%) |
| Sept 2014 | - | -13.05 K%(-2.6%) |
| June 2014 | - | -13.40 K%(+220.7%) |
| Mar 2014 | - | -4178.75%(+451.8%) |
| Dec 2013 | -1315.86%(+1931.9%) | -757.25%(-58.8%) |
| Sept 2013 | - | -1838.80%(-13.5%) |
| June 2013 | - | -2125.55%(+59.8%) |
| Mar 2013 | - | -1330.20%(+284.9%) |
| Dec 2012 | -64.76%(-96.3%) | -345.64%(>+9900.0%) |
| Sept 2012 | - | -3.35%(-99.9%) |
| June 2012 | - | -3370.91%(-38.2%) |
| Mar 2012 | - | -5454.04% |
| Dec 2011 | -1768.26% | - |
FAQ
- What is the all time high annual net margin for Onconova Therapeutics?
- What is the all time high quarterly net margin for Onconova Therapeutics?
What is the all time high annual net margin for Onconova Therapeutics?
Onconova Therapeutics all-time high annual net profit margin is -64.76%
What is the all time high quarterly net margin for Onconova Therapeutics?
Onconova Therapeutics all-time high quarterly net profit margin is 33.26%